Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/7/08 → 9/30/08 |
Long Term Safety and Tolerability of Satavaptan in Patients with Cirrhosis of the Liver That Have Been Previously Randomized and Completed Treatment in Any of the Phase III Studies: EFC4492, EFC4493 or EFC6682:
- Koch, Alvaro (PI)